A look at the latest advancements in the global rat model market unveils a study that examined the possible therapeutic methods for humans dealing with opioid addiction.
A look at the latest advancements in the global rat model market unveils a study that examined the possible therapeutic methods for humans dealing with opioid addiction. Published in the PNAS, the study was conducted by researchers at the University of California San Diego School of Medicine and inferred that permanent changes were produced in the brains of rats due to opioid dependence.
Further study using the same rat model technology concluded that the dependence on a potential opioid painkiller, oxycodone, resulted in permanent neuroadaptations of the CeA (central nucleus of the amygdala) at the level of the nociception system.
While suppression of nociceptin levels in the CeA led to a surge in the activation of GABA receptors in rats exhibiting a higher level of addiction to opioids. However, when nociceptin was restored to earlier levels, it resulted in the normalization of GABAergic transmission, thereby causing a significant reduction in the consumption of opioids.
Such deployments of rat model organisms help in the assessment of human behavior, assisting developers to come up with better vaccine solutions for various human ailments. According to the latest report by Global Market Insights, Inc., the rat model market size is estimated to surpass USD 1.8 billion by 2025.
The surging usage of rat trials for the development of new medical devices and assessing the efficacy and safety of new drugs is likely to drive the market growth through the forthcoming years. Key players in the rat model market comprise Janvier Labs, Transpogen Biopharmaceutical, Inc., Envigo, Charles River, Taconic Biosciences, Inc., Horizon Discovery Group plc, and others.
Few major trends propelling the industry growth comprise:
Rising deployment of rat models for understanding biological behavior to drive market outlook
An increase in the number of rat trials for understanding the nature of various cardiovascular diseases as well as diabetes is expected to stimulate industry expansion through the ensuing years.
The utilization of animal models for humans accounted for a dominating share of more than 80 per cent in 2018. The surging deployment of rat model technology for understanding the biological behavior of cancer and numerous autoimmune diseases is touted to influence segment growth over the estimated period.
To access sample pages of this report titled, “Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production And Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents, please click on the link below:
https://www.gminsights.com/request-sample/detail/4165
Increasing number of acquisitions and mergers by major industry players to boost rat model market share
The execution of numerous growth strategies, such as mergers and acquisitions, for increasing their geographic footprint by key industry participants is slated to drive rat model industry size through the coming years.
Considering an instance, Charles River Laboratories officially acquired Citoxlab in April 2019. The takeover would lead to a significant expansion of treatment alternatives, in turn improving the quality of life. The acquisition is further set to enhance the company’s position at the global level by backing the expansion of its scientific product portfolio.
U.S. to account for a commendable share in the rapidly progressing North America rat model market
According to the American Burn Association, emergency departments in the U.S. reported nearly 486,000 people for burn/fire injuries. Numerous research institutes in the country are, therefore, conducting common human and rat physiology tests for mimicking the human skin structure.
Similar developments have been instrumental in impelling rat model industry share in North America through the forecasted period. The U.S. market is poised to exhibit an appreciable CAGR of over 8.0 per cent through the projected period.
In a nutshell, surging demand for personalized humanized rat models on account of rising consumption of personalized medicines is expected to bolster humanized mouse & rat model market expansion over the coming years. Extensive utilization of rat model organisms in the process of drug discovery will further augment rat model market size through the analysis period.
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com